Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hecht Olsen

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|June 5, 2025
NaF-PET/CT imaging of atherosclerosis in type 2 diabetes: Associations with sex and history of cardiovascular events in a 2-year follow-up studyReza Piri, Jacob Volmer Stidsen, Jens Steen Nielsen, et al.
Acta Ophthalmologica|February 8, 2023
Retinal microvascular markers in type 2 diabetes subphenotypes and latent autoimmune diabetes of adultsFrederik N Pedersen, Jacob V Stidsen, Martin N Rasmussen, et al.
The American Journal of Cardiology|August 28, 2007
Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study)Marianne L Smebye, Emil K Iversen, Aud Høieggen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 29, 2023
The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristicsAnna Meta Dyrvig Kristensen, John Munkhaugen, Sigrun Halvorsen, et al.
Trials|December 7, 2015
The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trialAxel Cosmus Pyndt Diederichsen, Lars Melholt Rasmussen, Rikke Søgaard, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 23, 2020
Mean dietary salt intake in Nepal: A population survey with 24-hour urine collectionsDinesh Neupane, Anupa Rijal, Megan E Henry, et al.
Blood Pressure|June 10, 2017
The effects of baroreflex activation therapy on blood pressure and sympathetic function in patients with refractory hypertension: the rationale and design of the Nordic BAT studyDaniel Gordin, Fadl Elmula M Fadl Elmula, Bert Andersson, et al.
European Heart Journal|May 25, 2026
Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction populationAnna Meta Dyrvig Kristensen, Jarle Jortveit, Therese Holmager, et al.
Hypertension (Dallas, Tex. : 1979)|April 11, 2020
Nonvalidated Home Blood Pressure Devices Dominate the Online Marketplace in Australia: Major Implications for Cardiovascular Risk ManagementDean S Picone, Rewati A Deshpande, Martin G Schultz, et al.
BMJ Open|April 1, 2021
Lenient rate control versus strict rate control for atrial fibrillation: a protocol for the Danish Atrial Fibrillation (DanAF) randomised clinical trialJoshua Buron Feinberg, Michael Hecht Olsen, Axel Brandes, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
European Journal of Nuclear Medicine and Molecular Imaging|June 5, 2025
NaF-PET/CT imaging of atherosclerosis in type 2 diabetes: Associations with sex and history of cardiovascular events in a 2-year follow-up studyReza Piri, Jacob Volmer Stidsen, Jens Steen Nielsen, et al.
Acta Ophthalmologica|February 8, 2023
Retinal microvascular markers in type 2 diabetes subphenotypes and latent autoimmune diabetes of adultsFrederik N Pedersen, Jacob V Stidsen, Martin N Rasmussen, et al.
The American Journal of Cardiology|August 28, 2007
Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study)Marianne L Smebye, Emil K Iversen, Aud Høieggen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 29, 2023
The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristicsAnna Meta Dyrvig Kristensen, John Munkhaugen, Sigrun Halvorsen, et al.
Trials|December 7, 2015
The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trialAxel Cosmus Pyndt Diederichsen, Lars Melholt Rasmussen, Rikke Søgaard, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 23, 2020
Mean dietary salt intake in Nepal: A population survey with 24-hour urine collectionsDinesh Neupane, Anupa Rijal, Megan E Henry, et al.
Blood Pressure|June 10, 2017
The effects of baroreflex activation therapy on blood pressure and sympathetic function in patients with refractory hypertension: the rationale and design of the Nordic BAT studyDaniel Gordin, Fadl Elmula M Fadl Elmula, Bert Andersson, et al.
European Heart Journal|May 25, 2026
Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction populationAnna Meta Dyrvig Kristensen, Jarle Jortveit, Therese Holmager, et al.
Hypertension (Dallas, Tex. : 1979)|April 11, 2020
Nonvalidated Home Blood Pressure Devices Dominate the Online Marketplace in Australia: Major Implications for Cardiovascular Risk ManagementDean S Picone, Rewati A Deshpande, Martin G Schultz, et al.
BMJ Open|April 1, 2021
Lenient rate control versus strict rate control for atrial fibrillation: a protocol for the Danish Atrial Fibrillation (DanAF) randomised clinical trialJoshua Buron Feinberg, Michael Hecht Olsen, Axel Brandes, et al.
Pageof 13